Is lanreotide and/or interferon alfa an adequate therapy for neuroendocrine tumors?
- PMID: 14752089
- DOI: 10.1200/JCO.2004.99.175
Is lanreotide and/or interferon alfa an adequate therapy for neuroendocrine tumors?
Comment on
-
Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group.J Clin Oncol. 2003 Jul 15;21(14):2689-96. doi: 10.1200/JCO.2003.12.142. J Clin Oncol. 2003. PMID: 12860945 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
